Daily vitamin K supplementation improves anticoagulant stability

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 10, 2007, Pages 2043-2048

  Rombouts, E K ^a   Rosendaal, F R ^a   Van Der Meer, Felix J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anticoagulant stability; International Normalized Ratio; Vitamin K; Vitamin K antagonists

Indexed keywords

ANTIVITAMIN K; PHENPROCOUMON; PLACEBO; VITAMIN K GROUP;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTERY DISEASE; ARTICLE; BLEEDING; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG INDICATION; DRUG RESPONSE; DRUG STABILITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VALVE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK REDUCTION; THROMBOSIS; TREATMENT DURATION; VEIN THROMBOSIS; VITAMIN SUPPLEMENTATION;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; PHENPROCOUMON; PLACEBOS; RISK; TREATMENT OUTCOME; VITAMIN K;

EID: 34548857081     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02715.x     Document Type: Article

References (18)

1. Ansell J., Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 204S-33S.
2. Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: A systematic review and metaanalysis. Chest 2004; 126: 1938-45.
3. Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, Singer DE. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003; 349: 1019-26.
4. Levine MN, Raskob G, Landefeld S, Kearon C. Hemorrhagic complications of anticoagulant treatment. Chest 2001; 119: 108S-21S.
5. Khan T, Wynne H, Wood P, Torrance A, Hankey C, Avery P, Kesteven P, Kamali F. Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br J Haematol 2004; 124: 348-54.
6. Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: Prospective evidence from observational and randomized protocols. Am J Med 2004; 116: 651-6.
7. Kurnik D, Lubetsky A, Loebstein R, Almog S, Halkin H. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients. Ann Pharmacother 2003; 37: 1603-6.
8. Sconce E, Khan T, Mason J, Noble F, Wynne H, Kamali F. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost 2005; 93: 872-5.
9. Institute of Medicine FaNB. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington DC: National Academy Press, 2001
10. Rombouts EK, Rosendaal FR, van der Meer FJ. The effect of vitamin K supplementation on anticoagulant treatment. J Thromb Haemost 2006; 4: 691-2.
11. Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993; 69: 236-9.
12. Oldenburg J. Vitamin K intake and stability of oral anticoagulant treatment. Thromb Haemost 2005; 93: 799-800.
13. Bovill EG, Fung M, Cushman M. Vitamin K and oral anticoagulation: thought for food. Am J Med 2004; 116: 711-3.
14. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood 2007; 109: 2419-23.
15. Vermeer C, Hamulyak K. Vitamin K: Lessons from the past. J Thromb Haemost 2004; 2: 2115-7.
16. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey. JAMA 2002; 287: 337-44.
17. Geest-Daalderop JH, Sturk A, Levi M, Adriaansen HJ. Omvang en kwaliteit van de antistollingsbehandeling met cumarinederivaten door de Nederlandse trombosediensten. Ned Tijdschr Geneeskd 2004; 148: 730-5.
18. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ 2004; 329: 15-9.